Heterogeneous Type 4 Enhancement of Hepatocellular Carcinoma on Dynamic CT Is Associated With Tumor Recurrence After Radiofrequency Ablation

被引:53
|
作者
Kawamura, Yusuke [1 ]
Ikeda, Kenji [1 ]
Seko, Yuya [1 ]
Hosaka, Tetsuya [1 ]
Kobayashi, Masahiro [1 ]
Saitoh, Satoshi [1 ]
Kumada, Hiromitsu [1 ]
机构
[1] Toranomon Gen Hosp, Dept Hepatol, Minato Ku, Tokyo 1058470, Japan
关键词
dynamic CT; hepatocellular carcinoma; radiofrequency ablation; recurrence; surgical resection; PROGNOSTIC-FACTORS; RISK-FACTORS; HEPATECTOMY; UNIVARIATE; RESECTION;
D O I
10.2214/AJR.11.6843
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The aim of this study was to predict recurrence of hepatocellular carcinoma (HCC) from baseline dynamic CT images. MATERIALS AND METHODS. This retrospective study included 191 consecutive patients who underwent surgical resection or radiofrequency ablation (RFA) between January 2005 and September 2009 for the treatment of HCC. Enhancement on pretreatment arterial and portal phase dynamic CT images was classified into one of the four following enhancement patterns: Types 1 and 2 are homogeneous enhancement patterns without or with increased arterial blood flow, respectively; type 3 is a heterogeneous enhancement pattern with septations; and type 4 is an irregularly shaped ring structure enhancement pattern. Predictive factors for tumor recurrence including dynamic CT enhancement pattern were also evaluated. Moreover, risk factors including recurrence type (i.e., tumor number >= 10, portal vein invasion, or both) were evaluated in RFA-treated cases. RESULTS. Among 60 patients who underwent surgical resection, no statistical association was observed between dynamic CT enhancement patterns and recurrence rate. In contrast, in the 131 patients who underwent RFA, cumulative recurrence rates for each enhancement pattern were significantly different: Recurrence rates 2 years after RFA for patients with type 1, 2, 3, and 4 were 26.6%, 46.9%, 38.6%, and 77.8%, respectively (p = 0.042). Recurrence, which was defined as the presence of 10 or more nodules, portal vein invasion, or both occurred in nine of 131 patients (6.9%) in the RFA group. A multivariate Cox proportional hazards analysis revealed that the type 4 dynamic CT enhancement pattern is an independent factor for HCC recurrence (hazard ratio, 27.68; 95% CI, 6.82-112.33; p < 0.001). CONCLUSION. The pretreatment type 4 dynamic CT enhancement pattern can potentially be used to predict recurrence of HCC after RFA treatment.
引用
收藏
页码:W665 / W673
页数:9
相关论文
共 50 条
  • [21] Intrahepatic distant recurrence after radiofrequency ablation of hepatocellular carcinoma: relationship with portal hypertension
    Kim, Ran
    Jeong, Woo Kyoung
    Kang, Tae Wook
    Song, Kyoung Doo
    Lee, Min Woo
    Ahn, Soo Hyun
    Rhim, Hyunchul
    ACTA RADIOLOGICA, 2019, 60 (12) : 1609 - 1618
  • [22] Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation
    Kosaku Moribata
    Hideyuki Tamai
    Naoki Shingaki
    Yoshiyuki Mori
    Tatsuya Shiraki
    Shotaro Enomoto
    Hisanobu Deguchi
    Kazuki Ueda
    Izumi Inoue
    Takao Maekita
    Mikitaka Iguchi
    Masao Ichinose
    World Journal of Hepatology, 2012, (12) : 374 - 381
  • [23] Ultrasonogram of hepatocellular carcinoma is associated with outcome after radiofrequency ablation
    Moribata, Kosaku
    Tamai, Hideyuki
    Shingaki, Naoki
    Mori, Yoshiyuki
    Shiraki, Tatsuya
    Enomoto, Shotaro
    Deguchi, Hisanobu
    Ueda, Kazuki
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Ichinose, Masao
    WORLD JOURNAL OF HEPATOLOGY, 2012, 4 (12) : 374 - 381
  • [24] MicroRNA-34a expression is predictive of recurrence after radiofrequency ablation in early hepatocellular carcinoma
    Cui, Xianping
    Wu, Yaguang
    Wang, Zhiyi
    Liu, Xin
    Wang, Shikang
    Qin, Chengkun
    TUMOR BIOLOGY, 2015, 36 (05) : 3887 - 3893
  • [25] Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion
    Ippolito, Davide
    Bonaffini, Pietro Andrea
    Capraro, Cristina
    Leni, Davide
    Corso, Rocco
    Sironi, Sandro
    ABDOMINAL IMAGING, 2013, 38 (03): : 502 - 510
  • [26] Viable residual tumor tissue after radiofrequency ablation treatment in hepatocellular carcinoma: evaluation with CT perfusion
    Davide Ippolito
    Pietro Andrea Bonaffini
    Cristina Capraro
    Davide Leni
    Rocco Corso
    Sandro Sironi
    Abdominal Imaging, 2013, 38 : 502 - 510
  • [27] Pulmonary Metastasectomy after Radiofrequency Ablation of Hepatocellular Carcinoma
    Osuga, Takahiro
    Tanaka, Shingo
    Kubo, Tomohiro
    Hamaguchi, Kota
    Ito, Ryo
    Sakurada, Akira
    Ishikawa, Keidai
    Miyanishi, Koji
    CASE REPORTS IN ONCOLOGY, 2024, 17 (01): : 407 - 416
  • [28] Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors
    Lee, Hee Young
    Rhim, Hyunchul
    Lee, Min Woo
    Kim, Young-sun
    Choi, Dongil
    Park, Min Jung
    Kim, Young Kon
    Kim, Seong Hyun
    Lim, Hyo Keun
    EUROPEAN RADIOLOGY, 2013, 23 (01) : 190 - 197
  • [29] The arterial tumor enhancement pattern on contrast-enhanced computed tomography is associated with primary cancer death after radiofrequency ablation for small hepatocellular carcinoma
    Shimizu, Ryo
    Tamai, Hideyuki
    Mori, Yoshiyuki
    Shingaki, Naoki
    Maeshima, Shuya
    Nuta, Junya
    Maeda, Yoshimasa
    Moribata, Kosaku
    Muraki, Yosuke
    Deguchi, Hisanobu
    Inoue, Izumi
    Maekita, Takao
    Iguchi, Mikitaka
    Kato, Jun
    Ichinose, Masao
    HEPATOLOGY INTERNATIONAL, 2016, 10 (02) : 328 - 339
  • [30] Is radiofrequency ablation applicable for recurrent hepatocellular carcinoma after liver transplantation?
    Huang, Jiwei
    Yan, Lunan
    Wu, Hong
    Yang, Jiayin
    Liao, Mingheng
    Zeng, Yong
    JOURNAL OF SURGICAL RESEARCH, 2016, 200 (01) : 122 - 130